Radio-embolisation shows similar overall survival, improved toxicity vs sorafenib in hepatocellular carcinoma

Selective internal radiotherapy/radio-embolisation and sorafenib yield similar overall survival outcomes among patients with unresectable hepatocellular carcinoma, according to a study published in Journal of Clinical Oncology. Radio-embolisation may, however, have a superior toxicity profile.
Cancer Therapy Advisor